# Pathway Enrichment Analysis Report
# Generated: 2025-06-06 14:27:28

## Analysis Overview
- Input directory: /Users/aumchampaneri/Complement-OUD/Multi-Omics Study/results/snrna_scvi/differential_expression_edgeR
- Output directory: /Users/aumchampaneri/Complement-OUD/Multi-Omics Study/results/snrna_scvi/pathway_enrichment
- Contrasts analyzed: OUD_Effect_Male_vs_Female, OUD_Effect_Putamen_vs_Caudate, OUD_vs_Control_Caudate, OUD_vs_Control_Female, OUD_vs_Control_Male, OUD_vs_Control_Putamen, Pooled_OUD_vs_Control
- Gene universe size: 19505 genes

## Analysis Parameters
- ORA p-value cutoff: 0.05
- ORA q-value cutoff: 0.05
- GSEA p-value cutoff: 0.25
- Min gene set size: 10
- Max gene set size: 500

## Databases Analyzed
### Primary Databases:
1. Gene Ontology (GO) - Biological Process, Molecular Function, Cellular Component
2. KEGG Pathways
3. Reactome Pathways
4. MSigDB Hallmark Gene Sets

### Secondary Databases:
5. Disease Ontology (DO)
6. MSigDB C2 Curated Gene Sets
7. MSigDB C3 Motif Gene Sets (TF/miRNA targets)
8. MSigDB C7 Immunologic Signatures
9. MSigDB C8 Cell Type Signatures
10. WikiPathways
11. PharmGKB/PID Pathways

## Summary Statistics

### Enriched Pathways by Contrast and Database:

#### OUD_Effect_Male_vs_Female

- GO_BP ( ORA ): 5677 pathways
- GO_MF ( ORA ): 1229 pathways
- GO_CC ( ORA ): 659 pathways
- KEGG ( ORA ): 339 pathways
- Reactome ( ORA ): 1473 pathways
- DO ( ORA ): 930 pathways
- Hallmark ( ORA ): 50 pathways
- C2_Curated ( ORA ): 17 pathways
- C3_Motif ( ORA ): 3207 pathways
- C7_Immunologic ( ORA ): 4872 pathways
- C8_CellType ( ORA ): 750 pathways
- WikiPathways ( ORA ): 677 pathways
- PharmGKB ( ORA ): 191 pathways
- GO_BP ( GSEA ): 2125 pathways
- KEGG ( GSEA ): 189 pathways
- Hallmark ( GSEA ): 41 pathways
- C7_Immunologic ( GSEA ): 3882 pathways
- C8_CellType ( GSEA ): 505 pathways

#### OUD_vs_Control_Female

- GO_BP ( ORA ): 5757 pathways
- GO_MF ( ORA ): 1232 pathways
- GO_CC ( ORA ): 644 pathways
- KEGG ( ORA ): 340 pathways
- Reactome ( ORA ): 1485 pathways
- DO ( ORA ): 942 pathways
- Hallmark ( ORA ): 50 pathways
- C2_Curated ( ORA ): 17 pathways
- C3_Motif ( ORA ): 3224 pathways
- C7_Immunologic ( ORA ): 4872 pathways
- C8_CellType ( ORA ): 754 pathways
- WikiPathways ( ORA ): 670 pathways
- PharmGKB ( ORA ): 195 pathways
- GO_BP ( GSEA ): 1377 pathways
- KEGG ( GSEA ): 174 pathways
- Hallmark ( GSEA ): 43 pathways
- C7_Immunologic ( GSEA ): 2944 pathways
- C8_CellType ( GSEA ): 518 pathways

#### OUD_vs_Control_Male

- GO_BP ( ORA ): 278 pathways
- GO_MF ( ORA ): 42 pathways
- GO_CC ( ORA ): 22 pathways
- KEGG ( ORA ): 20 pathways
- Reactome ( ORA ): 23 pathways
- DO ( ORA ): 34 pathways
- Hallmark ( ORA ): 1 pathways
- C3_Motif ( ORA ): 100 pathways
- C7_Immunologic ( ORA ): 234 pathways
- C8_CellType ( ORA ): 65 pathways
- WikiPathways ( ORA ): 13 pathways
- GO_BP ( GSEA ): 2009 pathways
- KEGG ( GSEA ): 194 pathways
- Hallmark ( GSEA ): 32 pathways
- C7_Immunologic ( GSEA ): 3616 pathways
- C8_CellType ( GSEA ): 418 pathways

## OUD-Relevant Pathways
Found 2003 pathways related to opioid use disorder

### Top OUD-Relevant Pathways:

1 . DESCARTES_FETAL_CEREBRUM_MICROGLIA ( OUD_vs_Control_Female , p.adj = 2.47e-57 )
2 . ZHONG_PFC_MAJOR_TYPES_MICROGLIA ( OUD_vs_Control_Female , p.adj = 6.84e-50 )
3 . FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA ( OUD_vs_Control_Female , p.adj = 1.79e-46 )
4 . HU_FETAL_RETINA_MICROGLIA ( OUD_vs_Control_Female , p.adj = 1.71e-45 )
5 . DESCARTES_MAIN_FETAL_MICROGLIA ( OUD_vs_Control_Female , p.adj = 3.58e-26 )
6 . DESCARTES_FETAL_EYE_MICROGLIA ( OUD_vs_Control_Female , p.adj = 4.09e-17 )
7 . FAN_EMBRYONIC_CTX_ASTROCYTE_2 ( OUD_vs_Control_Female , p.adj = 7.36e-13 )
8 . ZHONG_PFC_MAJOR_TYPES_ASTROCYTES ( OUD_vs_Control_Female , p.adj = 7.56e-12 )
9 . WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA ( OUD_vs_Control_Female , p.adj = 4.5e-11 )
10 . positive regulation of cytokine production ( OUD_vs_Control_Female , p.adj = 1.35e-10 )

## Output Files

### Tables (CSV files):
- all_pathway_enrichment_results.csv: Combined results from all analyses
- pathway_enrichment_summary.csv: Summary statistics
- pathway_overlap_summary.csv: Analysis of pathway overlap between contrasts
- OUD_relevant_pathways.csv: Pathways relevant to opioid use disorder
- Individual enrichment results for each contrast and database

### Gene Lists:
- Up and down-regulated genes for each contrast
- Ranked gene lists for GSEA

## Analysis Notes
- Gene symbol to ENTREZ ID conversion performed using org.Hs.eg.db
- Statistical significance assessed using Benjamini-Hochberg FDR correction
- GSEA performed using signed ranking based on logFC and p-value
- Cross-contrast analysis focused on pathways significant in multiple contrasts
- All available contrasts from edgeR analysis were automatically detected and processed
- Global FDR correction applied across all databases and contrasts
- Effect sizes calculated with 95% confidence intervals
- Pathway redundancy analysis performed using Jaccard similarity
- Random gene set validation controls generated
- Quality control metrics tracked throughout analysis

## Statistical Rigor
- Gene conversion rate threshold: 70 %
- Global FDR threshold: 0.05
- Random validation sets: 1000
- Effect sizes reported with confidence intervals
- Multiple testing correction applied at global level
- Pathway redundancy assessed and reported

Analysis completed: 2025-06-06 14:27:28
